Talmadge JE - Search Results

1

Deoxyspergualin, a novel immunosuppressant, markedly inhibits human mixed lymphocyte reaction and cytotoxic T-lymphocyte activity in vitro.

Fujii H, Takada T, Nemoto K, Abe F, Fujii A, Talmadge JE, Takeuchi T. Fujii H, et al. Among authors: talmadge je. Int J Immunopharmacol. 1992 May;14(4):731-7. doi: 10.1016/0192-0561(92)90136-9. Int J Immunopharmacol. 1992. PMID: 1387869

2

Natural products. Preface.

Abe F, Cao X, Li XK, Talmadge JE. Abe F, et al. Among authors: talmadge je. Int Immunopharmacol. 2011 Mar;11(3):293-4. doi: 10.1016/j.intimp.2010.11.030. Epub 2010 Dec 13. Int Immunopharmacol. 2011. PMID: 21156220 No abstract available.

3

Introduction: Natural product-based drug discovery in Immunopharmacology.

Abe F, Marceau F, Talmadge JE. Abe F, et al. Among authors: talmadge je. Int Immunopharmacol. 2016 Aug;37:1-2. doi: 10.1016/j.intimp.2016.01.017. Epub 2016 Mar 15. Int Immunopharmacol. 2016. PMID: 26987504 No abstract available.

4

Editorial: Improving the data reproducibility and general interest of natural product submissions.

Marceau F, Abe F, Talmadge JE. Marceau F, et al. Among authors: talmadge je. Int Immunopharmacol. 2016 Aug;37:3-4. doi: 10.1016/j.intimp.2015.11.038. Epub 2015 Dec 8. Int Immunopharmacol. 2016. PMID: 26674722 No abstract available.

5

Chemoimmunotherapy with cyclophosphamide and bestatin in experimental metastasis in mice.

Abe F, Schneider M, Black PL, Talmadge JE. Abe F, et al. Among authors: talmadge je. Cancer Immunol Immunother. 1989;29(4):231-6. doi: 10.1007/BF00199209. Cancer Immunol Immunother. 1989. PMID: 2752391 Free PMC article.

6

Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets.

Younos IH, Abe F, Talmadge JE. Younos IH, et al. Among authors: talmadge je. Leuk Lymphoma. 2015;56(8):2251-63. doi: 10.3109/10428194.2014.987141. Epub 2015 Jan 21. Leuk Lymphoma. 2015. PMID: 25407654 Review.

7

Partial review of immunotherapeutic pharmacology in stem cell transplantation.

Bierman PJ, Abe F, Buyukberber S, Ino K, Talmadge JE. Bierman PJ, et al. Among authors: talmadge je. In Vivo. 2000 Jan-Feb;14(1):221-36. In Vivo. 2000. PMID: 10757081 Clinical Trial.

8

Therapeutic activity of sunitinib for Her2/neu induced mammary cancer in FVB mice.

Abe F, Younos I, Westphal S, Samson H, Scholar E, Dafferner A, Hoke TA, Talmadge JE. Abe F, et al. Among authors: talmadge je. Int Immunopharmacol. 2010 Jan;10(1):140-5. doi: 10.1016/j.intimp.2009.09.023. Epub 2009 Oct 12. Int Immunopharmacol. 2010. PMID: 19833232

9

Hematopoietic and hematologic properties of bestatin in normal and cyclophosphamide myelosuppressed mice.

Talmadge JE, Black PL, Pelus LM, Abe F. Talmadge JE, et al. Biomed Pharmacother. 1990;44(2):85-91. doi: 10.1016/0753-3322(90)90109-m. Biomed Pharmacother. 1990. PMID: 2224059

10

Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectors.

Gulen D, Abe F, Maas S, Reed E, Cowan K, Pirruccello S, Wisecarver J, Warkentin P, Northam M, Turken O, Coskun U, Senesac J, Talmadge JE. Gulen D, et al. Among authors: talmadge je. Int Immunopharmacol. 2008 Dec 20;8(13-14):1728-36. doi: 10.1016/j.intimp.2008.08.010. Epub 2008 Sep 13. Int Immunopharmacol. 2008. PMID: 18793758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

257 results

Search Page

Filters